Jing Lin

2.6k total citations
67 papers, 1.8k citations indexed

About

Jing Lin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jing Lin has authored 67 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 22 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Jing Lin's work include Lung Cancer Treatments and Mutations (9 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Jing Lin is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). Jing Lin collaborates with scholars based in China, Taiwan and United States. Jing Lin's co-authors include Qinong Ye, Jing‐Gung Chung, Lihua Ding, Jai‐Sing Yang, Long Cheng, Kai Jiang, Xiaojie Xu, Lihua Ding, Guang Wei Chen and Chang Niu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Jing Lin

60 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Lin China 26 1.1k 522 374 215 168 67 1.8k
Yanhui Yang China 27 1.0k 0.9× 402 0.8× 297 0.8× 184 0.9× 139 0.8× 143 2.2k
Scott J. Weir United States 29 928 0.8× 301 0.6× 560 1.5× 213 1.0× 191 1.1× 106 2.2k
Lajos Ráduly Romania 20 1.2k 1.1× 669 1.3× 330 0.9× 170 0.8× 77 0.5× 61 1.9k
Keyuan Zhou China 22 760 0.7× 424 0.8× 304 0.8× 130 0.6× 125 0.7× 73 1.4k
Haiyan Chen China 20 628 0.6× 405 0.8× 658 1.8× 167 0.8× 234 1.4× 63 1.7k
Luís Felipe Ribeiro Pinto Brazil 27 1.2k 1.1× 512 1.0× 424 1.1× 226 1.1× 75 0.4× 121 2.2k
Shu‐Xiang Cui China 24 1.0k 0.9× 546 1.0× 428 1.1× 105 0.5× 105 0.6× 69 1.8k
Rakesh Naidu Malaysia 27 1.2k 1.1× 464 0.9× 484 1.3× 168 0.8× 160 1.0× 91 2.4k
Yahui Ding China 23 976 0.9× 506 1.0× 247 0.7× 295 1.4× 125 0.7× 87 1.8k

Countries citing papers authored by Jing Lin

Since Specialization
Citations

This map shows the geographic impact of Jing Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Lin more than expected).

Fields of papers citing papers by Jing Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Lin. The network helps show where Jing Lin may publish in the future.

Co-authorship network of co-authors of Jing Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Lin. A scholar is included among the top collaborators of Jing Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Lin. Jing Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Jing, Xueli Yang, Cizhong Jiang, Xiaoguang Liu, & Jiejun Shi. (2025). Enhancing cancer susceptibility to disulfidptosis by inducing cell cycle arrest and impairing DNA repair. Theranostics. 16(2). 637–650.
2.
Liu, Mian, Pei Chen, Ning Li, et al.. (2025). FN1 shapes the behavior of papillary thyroid carcinoma through alternative splicing of EDB region. Scientific Reports. 15(1). 327–327.
3.
Zhang, Deyu, Chaoyang Liang, Ronghui Yang, et al.. (2023). HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis. Science Advances. 9(23). eade1155–eade1155. 2 indexed citations
4.
Chen, Yahong, et al.. (2023). Expression of RNA-m6A-related genes correlates with the HIV latent reservoir level and the CD4+ and CD8+T cell profiles of patients with AIDS. Cellular and Molecular Biology. 69(4). 125–132. 5 indexed citations
5.
6.
Zhang, Yifan, et al.. (2023). Traceable Lactate-Fueled Self-Acting Photodynamic Therapy against Triple-Negative Breast Cancer. Research. 7. 277–277. 19 indexed citations
7.
Li, Ling, Xiujuan Zhang, Xinxin Ren, et al.. (2023). Let-7b-5p inhibits breast cancer cell growth and metastasis via repression of hexokinase 2-mediated aerobic glycolysis. Cell Death Discovery. 9(1). 114–114. 15 indexed citations
8.
Xu, Ting, Xicheng Wang, Zhenghang Wang, et al.. (2021). Genomic profiles of BRAF inhibitor resistance mechanisms in metastatic colorectal cancer.. Journal of Clinical Oncology. 39(15_suppl). e15527–e15527. 2 indexed citations
9.
Sun, Yi, Li Gao, Wei Zhu, et al.. (2020). A comprehensive pan-cancer study of fibroblast growth factor receptor aberrations in Chinese cancer patients. Annals of Translational Medicine. 8(20). 1290–1290. 22 indexed citations
10.
Zhang, Yanan, et al.. (2020). Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect. Cancer Letters. 495. 53–65. 48 indexed citations
11.
Lin, Quan, Haoran Zhang, Jun Qian, et al.. (2019). The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients. Journal of Translational Medicine. 17(1). 298–298. 35 indexed citations
12.
Zhao, Lining, Dandan Guo, Jing Lin, & Rutao Liu. (2019). Responses of catalase and superoxide dismutase to low-dose quantum dots on molecular and cellular levels. Ecotoxicology and Environmental Safety. 181. 388–394. 25 indexed citations
13.
Ma, Jianguo, et al.. (2017). M7583 Is a Highly Selective and Potent Second Generation BTK Inhibitor for Treatment of B-Cell Malignancies. Blood. 130. 3845–3845. 4 indexed citations
14.
15.
Yang, Mei, et al.. (2015). Bisdemethoxycurcumin (BDMC) Alters Gene Expression-associated Cell Cycle, Cell Migration and Invasion and Tumor Progression in Human Lung Cancer NCI-H460 Cells.. PubMed. 29(6). 711–28. 7 indexed citations
16.
Zhu, Ping, et al.. (2014). Quality of Life of Male Spouse Caregivers for Breast Cancer Patients in China. Asian Pacific Journal of Cancer Prevention. 15(10). 4181–4185. 36 indexed citations
17.
Xu, Xiaojie, Zhongyi Fan, Lei Kang, et al.. (2013). Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. Journal of Clinical Investigation. 123(2). 630–45. 225 indexed citations
18.
Jiang, Kai, Zhihong Yang, Long Cheng, et al.. (2013). Mediator of ERBB2-driven Cell Motility (MEMO) Promotes Extranuclear Estrogen Receptor Signaling Involving the Growth Factor Receptors IGF1R and ERBB2*. Journal of Biological Chemistry. 288(34). 24590–24599. 24 indexed citations
19.
Zhou, Zhichao, et al.. (2012). FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression. Molecular Medicine Reports. 7(2). 649–653. 12 indexed citations
20.
Jiang, Qingyan, et al.. (2012). RNAi-mediated blocking of ezrin reduces migration of ectopic endometrial cells in endometriosis. Molecular Human Reproduction. 18(9). 435–441. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanhui Yang Breakdown of academic impact, for papers by Scott J. Weir Breakdown of academic impact, for papers by Lajos Ráduly Breakdown of academic impact, for papers by Keyuan Zhou Breakdown of academic impact, for papers by Haiyan Chen Breakdown of academic impact, for papers by Luís Felipe Ribeiro Pinto Breakdown of academic impact, for papers by Shu‐Xiang Cui Breakdown of academic impact, for papers by Rakesh Naidu Breakdown of academic impact, for papers by Yahui Ding
Rankless by CCL
2026